Cleared Traditional

K202862 - Gx-IVF, Gx-TL, Gx-MOPS PLUS (FDA 510(k) Clearance)

May 2021
Decision
228d
Days
Class 2
Risk

K202862 is an FDA 510(k) clearance for the Gx-IVF, Gx-TL, Gx-MOPS PLUS. This device is classified as a Media, Reproductive (Class II - Special Controls, product code MQL).

Submitted by Vitrolife Sweden AB (Västra Frölunda, SE). The FDA issued a Cleared decision on May 14, 2021, 228 days after receiving the submission on September 28, 2020.

This device falls under the Obstetrics & Gynecology FDA review panel. Regulated under 21 CFR 884.6180.

Submission Details

510(k) Number K202862 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2020
Decision Date May 14, 2021
Days to Decision 228 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF

Device Classification

Product Code MQL — Media, Reproductive
Device Class Class II - Special Controls
CFR Regulation 21 CFR 884.6180